Back
Corvus Pharmaceuticals Stock Predictions
Sponsored
CRVS
Sponsored
Try a Free Stock Analysis With Definitive Buy Sell Hold Ratings
Analyze Any Stock Free
Sell
27
CRVS
Corvus Pharmaceuticals
Last Price:
$5.35
Seasonality Move:
-3.05%
7 Day Trial
ALL ACCESS PASS
$
7
Free Stock Analysis Report: Get a clear concise Stock Rating
Analyze Any Stock FreeCorvus Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 17% based on the past 8 years of stock performance.
-
Corvus Pharmaceuticals has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
-
Is Corvus Pharmaceuticals Stock Undervalued?The current Corvus Pharmaceuticals [CRVS] share price is $5.65. The Score for CRVS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CRVS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 17% based on the past 8 years of stock performance.
Corvus Pharmaceuticals Stock Rating
Sell
27
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals overpriced?
-
Corvus Pharmaceuticals has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
Corvus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
10.00
52-Week Low:
1.30
Prediction Charts
Market Cap:
341.8M
Price in USD:
5.65
Volume:
388.8K
Beta:
1.13
Technical Analysis
SMA50:
7.63
SMA100:
6.48
SMA200:
4.28
52-Wk Change:
151.11%
Stock Predictions
-
Is Corvus Pharmaceuticals stock public?Yes, Corvus Pharmaceuticals is a publicly traded company.
-
What is the Corvus Pharmaceuticals stock quote today?The Corvus Pharmaceuticals stock price is 5.65 USD today.
-
How to buy Corvus Pharmaceuticals stock online?You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-18 | 5.00 | 4.71 | 5.20 | 3.77 |
Dec-19 | 4.67 | 5.09 | 5.10 | 4.30 |
Dec-20 | 5.02 | 5.00 | 5.34 | 4.73 |
Dec-23 | 4.95 | 4.55 | 4.95 | 4.52 |
Dec-24 | 4.56 | 4.90 | 4.94 | 4.55 |
Dec-26 | 4.84 | 5.29 | 5.40 | 4.84 |
Dec-27 | 5.22 | 5.21 | 5.43 | 5.10 |
Dec-30 | 5.01 | 5.25 | 5.28 | 4.93 |
Dec-31 | 5.24 | 5.35 | 5.36 | 4.99 |
Jan-2 | 5.46 | 5.43 | 5.68 | 5.25 |
Jan-3 | 5.43 | 5.83 | 5.93 | 5.38 |
Jan-6 | 5.97 | 6.03 | 6.47 | 5.83 |
Jan-7 | 6.05 | 5.75 | 6.14 | 5.75 |
Jan-8 | 5.78 | 5.65 | 5.89 | 5.53 |
Corvus Pharmaceuticals Earnings
Corvus Pharmaceuticals Earnings Report: Per Share Corvus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corvus Pharmaceuticals Forecast Revenue Growth
Corvus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.46 per share, and a decrease next year of $0.10 per share.
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.